metricas
covid
Buscar en
Medicina Clínica
Toda la web
Inicio Medicina Clínica Benefits of SGLT2 inhibitors combining with renin–angiotensin-system blockers ...
Journal Information

Statistics

Follow this link to access the full text of the article

Original article
Benefits of SGLT2 inhibitors combining with renin–angiotensin-system blockers on cardiovascular outcomes in chronic kidney disease patients: A systemic review and meta-analysis
Beneficios de los inhibidores de SGLT2 combinados con bloqueadores del sistema renina-angiotensina en los resultados cardiovasculares de los pacientes con enfermedad renal crónica: una revisión sistémica y un metaanálisis
Ting Liua,1, Rui Lib,1, Xiaoxia Wangb,1, Xingxing Gaob, Xiaodong Zhanga,
Corresponding author
zxdspl@163.com

Corresponding author.
a Department of Nephrology, The First Hospital of Shanxi Medical University, Taiyuan, China
b Shanxi Medical University, Taiyuan, China
Read
28
Times
was read the article
22
Total PDF
6
Total HTML
Share statistics
Article information
ISSN: 00257753
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 March 1 1 2
2023 March 1 3 4
2023 February 0 2 2
2022 October 1 0 1
2022 August 1 2 3
2022 July 2 12 14
2022 May 0 2 2

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos